New schizophrenia diagnosis lacked supporting clinical documentation
Summary
The facility failed to meet professional standards of care for one resident when it created a new diagnosis of schizophrenia without sufficient clinical documentation to support that diagnosis. Resident #3 was an older female with diagnoses including Alzheimer’s disease with late onset, schizophrenia, manic episode with psychotic symptoms, and insomnia due to a medical condition. Her most recent quarterly MDS showed clear speech, that she was usually understood and usually understood others, a BIMS score of 3, and no evidence of acute mental status change, inattention, disorganized thinking, or altered consciousness. Resident #3’s care plan, revised 12/04/2026, identified a need for antipsychotic medication and included monitoring, documenting, and reporting psychotropic drug complications. The diagnosis report showed schizophrenia was created on 01/05/2026. Her medication orders included Olanzapine 5 mg at bedtime for mania/schizophrenia, and medication consent documents listed use for psychotic disorder or mania/schizophrenia. A progress note dated 01/05/2026 stated the MD clarified the Olanzapine diagnosis to mania/schizophrenia after the resident’s family reported she used to speak to invisible people and that she had been placed on Olanzapine during an inpatient psychiatric stay. Record review of the resident’s available psychiatric hospitalization records from 01/25/2022 through 02/11/2022 showed diagnoses of dementia with behavioral disturbance, including at discharge, but did not show schizophrenia. Hospice referral documentation received by the facility listed Alzheimer’s disease, depressive episodes, anxiety disorders, and insomnia, and indicated Olanzapine was prescribed for sleep and anxiety. During interviews, the resident’s representative said he was unaware of the clinical indication for the antipsychotic, and the MD stated he had not reviewed documentation from the local mental health agency and had not seen documentation supporting schizophrenia. The DON, VP of Clinical Operations, and ADM also indicated the facility did not have the prior psychiatric hospitalization records available for review when the diagnosis was made.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.